{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:45:38Z","timestamp":1793375138992,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1053\/j.ajkd.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T10:04:36Z","timestamp":1412849076000},"page":"987-993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Membranous Nephropathy as a Manifestation of Graft-Versus-Host Disease: Association With HLA Antigen Typing, Phospholipase A2 Receptor, and C4d"],"prefix":"10.1053","volume":"64","author":[{"given":"Cathryn J.","family":"Byrne-Dugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Bernard","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Q.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Batal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2014.09.001_bib1","first-page":"21","article-title":"The biology of graft-versus-host reactions","volume":"62","author":"Billingham","year":"1966","journal-title":"Harvey Lect"},{"issue":"5","key":"10.1053\/j.ajkd.2014.09.001_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1053\/j.ajkd.2014.09.001_bib3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/bmt.2011.46","article-title":"Acute kidney injury following HCT: incidence, risk factors and outcome","volume":"46","author":"Lopes","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2014.09.001_bib4","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1681\/ASN.2006020118","article-title":"Chronic kidney disease in long-term survivors\u00a0of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment","volume":"17","author":"Hingorani","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.09.001_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2013.08.007","article-title":"The kidney effects of hematopoietic stem cell transplantation","volume":"21","author":"Sawinski","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2014.09.001_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ackd.2013.08.003","article-title":"Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation","volume":"21","author":"Jhaveri","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2014.09.001_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1705446","article-title":"Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"38","author":"Reddy","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2014.09.001_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/ajkd.2000.9787","article-title":"Hematopoietic cell transplantation-related nephropathy in Japan","volume":"36","author":"Imai","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2014.09.001_bib9","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/ndt\/gfq645","article-title":"The role of graft-versus-host disease in haematopoietic cell transplantation-associated glomerular disease","volume":"26","author":"Hu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2014.09.001_bib10","unstructured":"Collins AB, Satoskar AA, Beck LH Jr, et\u00a0al. De novo membranous glomerulonephritis (MGN) is immunologically distinct from idiopathic MGN and associated with C4d deposition and chronic humoral rejection [abstract]. Presented at: 11th Banff Conference on Allograft Pathology; June 2011; Enghien-les-Bains, France."},{"issue":"2","key":"10.1053\/j.ajkd.2014.09.001_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1399-0012.2010.01213.x","article-title":"De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney","volume":"25","author":"Honda","year":"2011","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2014.09.001_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MAJ.0b013e318267b5cd","article-title":"Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy","volume":"346","author":"Huang","year":"2013","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1053\/j.ajkd.2014.09.001_bib13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/TP.0b013e31828a947b","article-title":"Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus\u00a0recurrent membranous glomerulopathy","volume":"95","author":"Larsen","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ajkd.2014.09.001_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1871525711311010011","article-title":"The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature","volume":"11","author":"Niscola","year":"2013","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"6","key":"10.1053\/j.ajkd.2014.09.001_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00007890-199409270-00002","article-title":"Impact of\u00a0de novo membranous glomerulonephritis on the clinical course\u00a0after kidney transplantation","volume":"58","author":"Schwarz","year":"1994","journal-title":"Transplantation"},{"issue":"4","key":"10.1053\/j.ajkd.2014.09.001_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/modpathol.3801011","article-title":"Renal pathology in hematopoietic cell transplantation recipients","volume":"21","author":"Troxell","year":"2008","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1053\/j.ajkd.2014.09.001_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: recent advances and future challenges","volume":"8","author":"Ronco","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2014.09.001_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1744-313X.1995.tb00228.x","article-title":"An analysis of HLA class II gene polymorphism in British and Greek idiopathic membranous nephropathy patients","volume":"22","author":"Vaughan","year":"1995","journal-title":"Eur J Immunogenet"},{"issue":"24","key":"10.1053\/j.ajkd.2014.09.001_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM197912133012401","article-title":"A\u00a0controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the\u00a0Adult Idiopathic Nephrotic Syndrome","volume":"301","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2014.09.001_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"5720","key":"10.1053\/j.ajkd.2014.09.001_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","article-title":"Controlled trial of prednisone in adult patients with the nephrotic syndrome","volume":"3","author":"Black","year":"1970","journal-title":"Br Med J"},{"issue":"7","key":"10.1053\/j.ajkd.2014.09.001_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2014.09.001_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.2012070730","article-title":"Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy","volume":"24","author":"Coenen","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2014.09.001_bib24","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.ajkd.2014.09.001_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2014.09.001_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2012.05.017","article-title":"T\u00a0Cells, murine chronic graft-versus-host disease and autoimmunity","volume":"39","author":"Eisenberg","year":"2012","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1053\/j.ajkd.2014.09.001_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2010.01.005","article-title":"Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression","volume":"136","author":"Foster","year":"2010","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.09.001_bib28","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1053\/ajkd.2000.8302","article-title":"Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient","volume":"36","author":"Ohsawa","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2014.09.001_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.ajkd.2012.09.020","article-title":"Kidney complications of hematopoietic stem cell transplantation","volume":"61","author":"Singh","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2014.09.001_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2014.09.001_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ejh.12149","article-title":"Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant","volume":"91","author":"Fraile","year":"2013","journal-title":"Eur J Haematol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614011822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614011822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:30:36Z","timestamp":1759458636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638614011822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0272638614011822"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.09.001","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membranous Nephropathy as a Manifestation of Graft-Versus-Host Disease: Association With HLA Antigen Typing, Phospholipase A2 Receptor, and C4d","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}